@article{TLCR98990,
author = {Baohui Han and Lin Wu and Runxiang Yang and Hongbo Wu and Wei Li and Yan Yu and Mingjuan Zhang and Hongmei Sun and Tianqing Chu and Fukuan Zhong and Yong Fang and Rong Wu and Tao Bian and Xiaoqing Guo and Meili Sun and Yanming Zhang and Lianke Liu and Xuewen Liu and Yueyin Pan and Ou Jiang and Zonghui Wei and Haifeng Lin and Wei Guo and Jian Fang and Jialei Wang and Cuimin Ding and Yanping Hu and Feng Ye and Wu Zhuang and Shucheng Ye and Lihong Wang and Zhe Huang and Chang Liu and Ling Yang and Jinling Wang and Liangzhi Xie},
title = {Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial},
journal = {Translational Lung Cancer Research},
volume = {14},
number = {4},
year = {2025},
keywords = {},
abstract = {},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/98990}
}